Nabiha Saklayen
Nabiha Saklayen is CEO and co-founder of Cellino, where her team is spearheading the biomanufacturing of regenerative medicines to make “Your Cells, Your Cure” a reality for patients in an aging world. As a purpose-driven physicist, she focused her Ph.D. research on inventing bio/nanophotonics technologies to unlock precision cellular engineering for human health applications. Nabiha’s expertise and passion for patient impact inspired Cellino’s proprietary approach: an autonomous, optical bioprocess that unlocks the ultra-scalable manufacturing of regenerative medicines. Nabiha is a TED speaker and the inaugural Tory Burch Foundation Fellow in Genomics at the Innovative Genomics Institute, led by Nobel Laureate Dr. Jennifer Doudna. She received her Ph.D. in Physics from Harvard University as a Howard Hughes Medical Institute International Fellow. Nabiha also co-created I Am A Scientist, an educational program in 50 states that inspires children to explore science. She is a global citizen who grew up in Saudi Arabia, Bangladesh, Germany, and Sri Lanka.
â€
Cellino
Senior Leadership AIxBioPharma Luncheon - Inflection Points: Lessons from Computing and Cloud to Catalyze AI in Bio
-
This invite-only luncheon brings together a curated group of senior leaders driving the convergence of AI and BioPharma. Hosted at SynBioBeta 2025, the event is primarily a unique opportunity to network with C-level executives, investors, and researchers shaping the future of AIxBIO. In addition to high-level networking, the luncheon will feature a panel conversation titled Inflection Points: Lessons from Computing and Cloud to Catalyze AI in Bio. Moderated by Celestine Schnugg, Founding Partner at Boom Capital, the session will explore how decades of innovation in computing and cloud infrastructure can inform the next wave of breakthroughs in biology. Joining the conversation are Sandy Pentland, a pioneer in data science and professor at MIT; Richard Socher, CEO of You.com and former Chief Scientist at Salesforce; Simon Kohl, Co-Founder and CEO of Latent Labs; and Nabiha Saklayen, Co-Founder and CEO of Cellino. Together, they will examine how lessons from past technological inflection points can be applied—and adapted—to the emerging era of AI-driven biology. https://lu.ma/a8odlz08
